Hironao Yazaki is the Life Science Sector Leader at EY Japan. He provides audit services across the sector, including the pharmaceutical and medical equipment industry, bio ventures and hospitals.
Drawing on his extensive experience in life sciences and auditing, Hironao has served as local government commissioner, university lecturer, and as a committee member of the Japan Institute of Chartered Public Accountants (JICPA). He has also authored a guide to the impact of IFRS on the pharmaceutical industry.
Prior to joining EY, he worked in the manufacturing industry.
He is a Japan Certified Public Accountant and a graduate of the Faculty of Economics at Tokyo’s Keio University.
Building a better working world
"In the last few years, we have seen the proliferation of chronic diseases and health-related problems in an aging population. In parallel, there have been major changes in medicine and the market due to scientific progress, technological development, and an overall increase in the amount of data available to us.
Helping to create a healthier society is the mission of the EY Life Sciences Sector. I hope to build a better working world by supporting industry and society to improve health outcomes."
